SCHEMBL29891752

SCHEMBL29891752

COc1ccccc1-c1nccc(=O)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 4/20 0.51
▸ AURKA O14965 1/20 0.51
▸ FGFR1 P11362 2/20 0.50
▸ FGFR2 P21802 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.47
▸ MPO P05164 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ DCUN1D1 Q96GG9 2/20 0.46
▸ CCNB2 O95067 1/20 0.46
▸ CDK1 P06493 1/20 0.46
▸ CCNB1 P14635 1/20 0.46
▸ GSK3A P49840 1/20 0.46
▸ GSK3B P49841 1/20 0.46
▸ CDK5 Q00535 1/20 0.46
▸ CDK5R1 Q15078 1/20 0.46
▸ CCNB3 Q8WWL7 1/20 0.46
▸ GAA P10253 2/20 0.45
▸ TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9296042 0.82 PDE5A (0.57) PDE5AALDH1A1CYP1A2CASP1HSD17B10
SCHEMBL14340862 0.78 HPGD (0.45) ALDH1A1CYP1A2CYP3A4DCUN1D1HSD17B10
SCHEMBL30141985 0.78 HPGD (0.45) ALDH1A1CYP1A2CYP3A4DCUN1D1HSD17B10
SCHEMBL13851602 0.75 KDM4E (0.64) PDE5AAURKAFGFR1FGFR2MPO
SCHEMBL3403152 0.75 ADRA1A (0.54) PDE5AAURKAALDH1A1DCUN1D1CCNB2
SCHEMBL29856941 0.75 NPC1 (0.45) ALDH1A1DCUN1D1CDK1GSK3AGAA
SCHEMBL29360270 0.75 ADRA1A (0.54) PDE5AAURKAALDH1A1DCUN1D1CCNB2
SCHEMBL11683708 0.74 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP3A4CYP2D6GAA
SCHEMBL23736205 0.73 SMPD3 (0.51) PDE5AAURKAFGFR1FGFR2ALDH1A1
SCHEMBL7591056 0.72 PTGES (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313295-A1 PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19) Almac Discovery Limited (GB) 2024-02-07 — — EP disclosed
WO-2022200523-A1 PHARMACEUTICALS COMPOUNDS AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19) ALMAC DISCOVERY LIMITED (GB) 2022-09-29 — — WO disclosed
Send feedback